Altimmune
在场
高管
查看带有其 21 名主要高管的组织结构图
Altimmune 搜索最多的简介
- Vipin Garg, Director, President and Chief Executive Officer
- Mitchel Sayare, Executive Chairman of the Board
- Philip Hodges, Director
高管在Altimmune变化
- Greg Weaver已作为Chief Financial Officer加入公司 (新闻发布的2024十一月12号).
- Richard Eisenstadt, Chief Financial Officer, 已经去世。我们深感遗憾 (新闻发布的2024六月27号).
创建提醒
跟踪 Altimmune 的高管变动
药店
Altimmune 拥有 1,842 家竞争者，其中包括 Pfizer (美国(美洲))、Johnson & Johnson (美国(美洲)) 和 Sanofi (法国)。
Popular M&A news in 药店
- BeiGene将改名为BeOne Medicines。 (公布2024十一月15号).
- GlycoMimetics and Crescent Biopharma have announced they will merge (公布2024十一月15号)..
- Grace Therapeutics将在Oct 25, 2024将其名称改为Grace Therapeutics。 (公布2024十月27号).
药店 行业的其他推荐联系人
消息
Altimmune 的最新新闻稿
- Altimmune Presents New Data on the Effect of Pemvidutide on Inflammatory Lipids in Subjects with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) at The Liver Meeting® 2024 – Altimmune
- Altimmune Announces Third Quarter 2024 Financial Results and Provides a Business Update – Altimmune
- Press Releases – Altimmune
- Altimmune to Report Second Quarter 2022 Financial Results and Provide Business Update on August 11 – Altimmune
- Altimmune Announces Oral Presentation of Pemvidutide Clinical Data at Upcoming EASL International Liver Congress™ on June 25, 2022 – Altimmune
- Press Releases – Altimmune
- Press Releases – Altimmune
- Altimmune to Participate at Two Upcoming Investor Conferences – Altimmune
- Altimmune Announces Oral Presentation of Pemvidutide Clinical Data at Upcoming American Diabetes Association Scientific Sessions June 6, 2022 – Altimmune
- Altimmune to Present Pemvidutide Clinical Data at Upcoming Global NASH Congress May 27, 2022 – Altimmune
- View more press releases Close
通过电子邮件
